First Study of Oral Cysteamine in Cystic Fibrosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Cystic Fibrosis
Interventions
DRUG

Cysteamine

Dose will be increased weekly from 450mg od to 450mg bd, to 450mg tds to 450mg qds, will remain on highest dose for 2 weeks

Trial Locations (1)

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

All Listed Sponsors
collaborator

Cystic Fibrosis Trust

OTHER

collaborator

NHS Grampian

OTHER_GOV

collaborator

University of Huddersfield

OTHER

lead

University of Aberdeen

OTHER

NCT02212431 - First Study of Oral Cysteamine in Cystic Fibrosis | Biotech Hunter | Biotech Hunter